Hatim Sabaawy, MD, PhD, MS

Professor, Medicine-Medical Oncology


FacultyPhoto
Languages
English, French
Department
Medicine-Medical Oncology

Professional Titles

  • Associate Director of Translational Research
  • Professor of Medicine

Publications

  • Liu L, Davis S, Yusuff S, Strange A, Zhuang Y, Vaddi P, Flaherty K, Jara K, Kramer J, Archer C, Lee S, Gao B, van Bokhoven A, Wang W, Pine SR, Nakamura T, Sabaawy HE. Evolutionary conserved reciprocal senescence and tumor suppressor signals limit lifetime cancer. BioRxiv 2024. Doi: 10.1101/2024.12.28.630560. ID: 630560.
  • Sabaawy HE, Broggini M, Gupta SK. Patient-derived tumor models for drug development. Front Oncol. 2023;13:1243534. PubMed PMID: 37483498
  • Zhong H, Lu W, Tang Y, Wiel C, Wei Y, Cao J, Riedlinger G, Papagiannakopoulos T, Guo JY, Bergo MO, Kang Y, Ganesan S, Sabaawy HE, Pine SR. SOX9 drives KRAS-induced lung adenocarcinoma progression and suppresses anti-tumor immunity. Oncogene. 2023 Jun;42(27):2183-2194. PubMed PMID: 37258742
  • Laureano AS, Flaherty K, Hinman AM, Jadali A, Nakamura T, Higashijima SI, Sabaawy HE, Kwan KY. shox2 is required for vestibular statoacoustic neuron development. Biol Open. 2022 Dec 15;11(12). PubMed PMID: 36594417
  • Castellano GM, Zeeshan S, Garbuzenko OB, Sabaawy HE, Malhotra J, Minko T, Pine SR. Inhibition of Mtorc1/2 and DNA-PK via CC-115 Synergizes with Carboplatin and Paclitaxel in Lung Squamous Cell Carcinoma. Mol Cancer Ther. 2022 Sep 6;21(9):1381-1392. PubMed PMID: 35732569
  • Kim IY, Mitrofanova A, Panja S, Sterling J, Srivastava A, Kim J, Kim S, Singer EA, Jang TL, Ghodoussipour S, Saraiya B, Mayer T, Sabaawy HE, Yuh B, Byun SS, Kim WJ, Horie S. Genomic analysis and long-term outcomes of a phase 1 clinical trial on cytoreductive radical prostatectomy. Prostate Int. 2022 Jun;10(2):75-79. PubMed PMID: 35510081
  • Al-Zubaydi F, Gao D, Kakkar D, Li S, Holloway J, Szekely Z, Chan N, Kumar S, Sabaawy HE, Love S, Sinko PJ. Breast intraductal nanoformulations for treating ductal carcinoma in situ II: Dose de-escalation using a slow releasing/slow bioconverting prodrug strategy. Drug Deliv Transl Res. 2022 Jan;12(1):240-256. PubMed PMID: 33590464

Professional Memberships

  • American Society of Clinical Oncology (ASCO), Full member
  • American Association of Cancer Research (AACR), Full member

Practice Locations

University of Colorado Cancer Center - Anschutz Medical Campus
1665 Aurora Ct
Aurora, CO 80045
720-848-0300

Hospital Affiliation
  • University of Colorado Hospital

Clinical Interests
Personalized Medicine, Molecular Diagnostics, Immunotherapy, Precision Therapy